An Adaptive-design Prospective Cohort Study of Watch and Wait Strategy in Patients With Locally Advanced Rectal Cancer
Condition: Rectal Cancer Interventions: Drug: Capecitabine (Xeloda) Pharmacogenetic Test Reagents; Drug: irinotecan; Radiation: IMRT; Drug: Oxaliplatin; Drug: 5Fluorouracil; Drug: Tislelizumab Sponsor: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Eloxatin | Intensity-Modulated Radiation Therapy | Rectal Cancers | Research | Study | Xeloda